Chronomodulated Administration of Oxaliplatin plus Capecitabine (XELOX) as First Line Chemotherapy in Metastatic Colorectal Cancer Patients: Phase II Brunch Regimen Study.
Yazar
Pilanci, Kezban Nur
Ciftci, Rumeysa
Okyar, Alper
Koksal, Ulkuhan
Saglam, Esra Kaytan
Saglam, Sezer
Yucel, Serap
Kara, Zeliha Pala
Ordu, Cetin
Namal, Esat
Üst veri
Tüm öğe kaydını gösterBağlantı
http://hdl.handle.net/20.500.12627/41327https://doi.org/10.1200/jco.2015.33.15_suppl.e14646
Koleksiyonlar
- Bildiri [64839]